Key Players in Vascular Embolization Market Focus on Product Innovation and Development of Advanced Embolic Agents

𝐖𝐡𝐚𝐭 𝐢𝐬 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐞𝐦𝐛𝐨𝐥𝐢𝐳𝐚𝐭𝐢𝐨𝐧?

Vascular embolization, also known as embolotherapy, is a medical procedure that involves the use of embolic agents to block or occlude blood vessels. Embolic agents can be solid particles, liquid substances, or devices that are introduced into the bloodstream through a catheter and directed to the site of the target vessel.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐫𝐞𝐩𝐨𝐫𝐭 𝐬𝐚𝐦𝐩𝐥𝐞 - https://www.alliedmarketresearch.com/request-sample/13615?utm_source=AMR&utm_medium=research&utm_campaign=ML

𝐓𝐡𝐞 𝐞𝐦𝐛𝐨𝐥𝐢𝐜 𝐚𝐠𝐞𝐧𝐭𝐬 𝐜𝐚𝐧 𝐛𝐞 𝐮𝐬𝐞𝐝 𝐭𝐨 𝐭𝐫𝐞𝐚𝐭 𝐚 𝐯𝐚𝐫𝐢𝐞𝐭𝐲 𝐨𝐟 𝐦𝐞𝐝𝐢𝐜𝐚𝐥 𝐜𝐨𝐧𝐝𝐢𝐭𝐢𝐨𝐧𝐬, 𝐢𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠:

𝐓𝐮𝐦𝐨𝐫𝐬: : Embolization can be used to treat tumors by cutting off the blood supply to the tumor, which can shrink or kill the tumor. This technique is commonly used for liver, kidney, and lung tumors.

𝐀𝐧𝐞𝐮𝐫𝐲𝐬𝐦𝐬: Embolization can be used to treat aneurysms by blocking the blood flow to the weakened area of the blood vessel. This can prevent the aneurysm from rupturing.

𝐀𝐫𝐭𝐞𝐫𝐢𝐨𝐯𝐞𝐧𝐨𝐮𝐬 𝐦𝐚𝐥𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧𝐬 (𝐀𝐕𝐌𝐬): Embolization can be used to treat AVMs by blocking the abnormal connections between arteries and veins. This can reduce the risk of bleeding and other complications.

𝐁𝐥𝐞𝐞𝐝𝐢𝐧𝐠: Embolization can be used to stop bleeding by blocking the blood vessel that is causing the bleeding. This technique is commonly used for gastrointestinal bleeding, uterine bleeding, and traumatic bleeding.

𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 (282 𝐏𝐚𝐠𝐞𝐬 𝐏𝐃𝐅 𝐰𝐢𝐭𝐡 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐂𝐡𝐚𝐫𝐭𝐬, 𝐓𝐚𝐛𝐥𝐞𝐬, 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬) @ https://www.alliedmarketresearch.com/checkout-final/b8e4a1cdca834ac2b914381c84185249?utm_source=AMR&utm_medium=research&utm_campaign=ML

On the basis of product, the embolic agents segment dominated the vascular embolization market size and is also expected to register highest CAGR, owing to wide availability and new product launches & approval of the products.

On the basis of application, the neurology segment was the major revenue contributor in 2021, owing to surge in the brain aneurysm. However, oncology is expected to register highest CAGR in vascular embolization market forecast from 2022 to 2031, owing to surge in the incidence of cancer cases.

Moreover, developing countries in Asia-Pacific and LAMEA are expected to witness considerable growth in the near future, owing to surge in healthcare infrastructure, increase in affordability, and rise in chronic diseases and others. Therefore, these factors are expected to provide numerous opportunities for the growth of the market in developing nations.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 - https://www.alliedmarketresearch.com/purchase-enquiry/13615?utm_source=AMR&utm_medium=research&utm_campaign=ML

𝐊𝐞𝐲 𝐟𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐬𝐭𝐮𝐝𝐲

• On the basis of product, the embolic agents segment was highest contributor to the vascular embolization industry in 2021.

• On the basis of application, the neurology segment dominated the vascular embolization market share in 2021, and is expected to continue this trend during the forecast period.

• On the basis of end user, the hospitals & clinics segment dominated the vascular embolization industry in 2021, and is expected to grow at a higher CAGR.

• On the basis of region, North America generated the largest revenue share in 2021, however, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 -
• Abbott Laboratories.
• Balt Group,
• Boston Scientific Corporation,
• Cook Medical,
• Johnson and Johnson,
• Kaneka Corporation,
• Medtronic Plc,
• Merit Medical,
• Stryker Corporation,
• Terumo Medical Corporation.

𝐊𝐧𝐨𝐰 𝐌𝐨𝐫𝐞-
https://www.alliedmarketresearch.com/vascular-embolization-market-A13246

𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭𝐬-
𝐌𝐞𝐧𝐭𝐚𝐥 𝐡𝐞𝐚𝐥𝐭𝐡 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐭𝐫𝐞𝐧𝐝𝐬 - https://www.alliedmarketresearch.com/mental-health-market-A11770

𝐒𝐮𝐫𝐠𝐢𝐜𝐚𝐥 𝐜𝐥𝐚𝐦𝐩𝐬 - https://www.alliedmarketresearch.com/surgical-clamps-market-A13381

𝐂𝐨𝐧𝐣𝐮𝐧𝐜𝐭𝐢𝐯𝐢𝐭𝐢𝐬 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 - https://www.alliedmarketresearch.com/conjunctivitis-treatment-market-A17599

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com

Alied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.